// App-Quantinova.ai

TCT-408 : Three-year clinical outcome of Everolimus-eluting bioresorbable scaffold vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction - TROFI II trial

Researchers

Presenter

  • Patrick Serruys

Principal Investigators

  • Taku Asano

  • Salvatore Brugaletta

  • Lorenz Raber

  • Yoshinobu Onuma

  • Stephan Windecker

  • Manel Sabate

Medical Centers

  • Imperial College, London, United Kingdom

  • University of Barcelona, Barcelona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • University Hospital of Bern, Bern, Switzerland

Locations

  • United Kingdom

  • Spain

  • Netherlands

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved